[Treatment of extrapyramidal hyperkinesis].
D000293:Adolescent; D000328:Adult; D000553:Ambulatory Care; D001480:Basal Ganglia Diseases / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D001966:Bromine / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use*; D002908:Chronic Disease; D004338:Drug Combinations; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D010634:Phenobarbital / Q000627:therapeutic use*; D011208:Powders; D014508:Urea / Q000627:therapeutic use; D014631:Valerates / Q000627:therapeutic use
D001562:Benzimidazoles; D001593:Benzyl Compounds; D004338:Drug Combinations; D010276:Parasympatholytics; D011208:Powders; D014631:Valerates; D002110:Caffeine; D014508:Urea; D010208:Papaverine; D001966:Bromine; D010634:Phenobarbital
K lecheniiu ékstrapiramidnykh giperkinezov.